Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | EGFR | P00533 | 14/20 | 0.52 |
| ▸ | BRAF | P15056 | 1/20 | 0.50 |
| ▸ | KDR | P35968 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | FBP1 | P09467 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8870722 | 0.84 | EGFR (0.57) | EGFRBRAFKDRMAPK1ERBB2 | |
| SCHEMBL2985878 | 0.83 | EGFR (0.68) | EGFRBRAFKDRFBP1ERBB2 | |
| SCHEMBL27923390 | 0.82 | EGFR (0.67) | EGFRBRAFKDRMAPTERBB2 | |
| SCHEMBL2988532 | 0.81 | EGFR (0.59) | EGFRFBP1MAPK1ERBB2 | |
| SCHEMBL2985880 | 0.80 | FBP1 (0.54) | ALDH1A1SMN1; SMN2LMNAKMT2AEGFR | |
| SCHEMBL25249103 | 0.80 | EGFR (0.45) | ALDH1A1SMN1; SMN2LMNAKMT2AEGFR | |
| SCHEMBL7811124 | 0.79 | EGFR (0.77) | EGFRFBP1MAPK1ERBB2 | |
| SCHEMBL8871984 | 0.78 | EGFR (0.58) | LMNAKMT2AEGFRMAPTMAPK1 | |
| SCHEMBL8315497 | 0.78 | EGFR (0.79) | EGFRFBP1MAPK1ERBB2 | |
| Hydrochloric Acid SCHEMBL7809280 | 0.78 | EGFR (0.75) | EGFRFBP1MAPK1ERBB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5616582-A | Use as anticancer agents; e.g. gefitinib | ZENECA LIMITED (GB) | 1997-04-01 | — | — | US | disclosed |
| EP-0566226-B1 | Quinazoline derivatives | ZENECA LTD (GB) | 1995-11-08 | — | — | EP | disclosed |
| US-5457105-A | anticancer use; e.g. 4-(3'-chloro-4'-fluoroanilino)-6,7-dimethoxyquinazoline (gefitinib) | ZENECA LIMITED (GB) | 1995-10-10 | — | — | US | disclosed |
| EP-0566226-A1 | Quinazoline derivatives | ZENECA LIMITED (GB) | 1993-10-20 | — | — | EP | disclosed |